{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:09:52Z","timestamp":1773281392626,"version":"3.50.1"},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2009]]},"DOI":"10.3129\/i09-153","type":"journal-article","created":{"date-parts":[[2009,12,22]],"date-time":"2009-12-22T12:03:20Z","timestamp":1261483400000},"page":"e61-e62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Management of endogenous cryptococcal endophthalmitis with voriconazole"],"prefix":"10.1016","volume":"44","author":[{"given":"Jos\u00e9 I.","family":"Vela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"D\u00edaz-Cascajosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferran","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noem\u00ed","family":"Rosell\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Buil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3129\/i09-153_bib1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/bjo.2007.136515","article-title":"Voriconazole in the treatment of fungal eye infections: a review of current literature","volume":"92","author":"Hariprasad","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.3129\/i09-153_bib2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/clinids\/14.5.1069","article-title":"Cryptococcal endophthalmitis: case report and review","volume":"14","author":"Crump","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.3129\/i09-153_bib3","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/AAC.48.6.2014-2020.2004","article-title":"Effects of voriconazole on Cryptococcus neoformans","volume":"48","author":"van Duin","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.3129\/i09-153_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archopht.122.1.42","article-title":"Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans","volume":"122","author":"Hariprasad","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.3129\/i09-153_bib5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/IAE.0b013e31818d4b9b","article-title":"Intravitreal voriconazole: in vitro safety-profile for fungal endophthalmitis","volume":"29","author":"Kernt","year":"2009","journal-title":"Retina"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418209800707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418209800707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:01:38Z","timestamp":1757793698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418209800707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"alternative-id":["S0008418209800707"],"URL":"https:\/\/doi.org\/10.3129\/i09-153","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of endogenous cryptococcal endophthalmitis with voriconazole","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3129\/i09-153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}